PHARMACOGENETICS OF RESPONSE TO DOPAMINERGIC THERAPY IN PATIENTS WITH PARKINSON'S DISEASE

A. S Fedosova , N. N Shipilova

Genes & Cells ›› 2020, Vol. 15 ›› Issue (3S) : 151 -152.

PDF
Genes & Cells ›› 2020, Vol. 15 ›› Issue (3S) :151 -152. DOI: 10.23868/gc123108
Articles
oration

PHARMACOGENETICS OF RESPONSE TO DOPAMINERGIC THERAPY IN PATIENTS WITH PARKINSON'S DISEASE

Author information +
History +
PDF

Abstract

Cite this article

Download citation ▾
A. S Fedosova, N. N Shipilova. PHARMACOGENETICS OF RESPONSE TO DOPAMINERGIC THERAPY IN PATIENTS WITH PARKINSON'S DISEASE. Genes & Cells, 2020, 15(3S): 151-152 DOI:10.23868/gc123108

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

De Lau L. M. L., Breteler M. M.B. The Lancet Neurology. 2006; 5(6): 525-535.

[2]

Weintraub D., Siderowf A.D., Potenza M.N. et al. Archives of neurology 2006; 63(7): 969-973.

RIGHTS & PERMISSIONS

Eco-Vector

PDF

47

Accesses

0

Citation

Detail

Sections
Recommended

/